Browse Tag

analyst outlook

NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Stock (NVDA) News, Forecasts and Analyst Outlook After Dec. 20, 2025: China Export Review, Blackwell “Cloud Loophole,” and 2026 Catalysts

NVIDIA Corporation (NASDAQ: NVDA) is heading into the final full stretch of 2025 with investors juggling two forces that regularly drive the stock: AI infrastructure demand and geopolitics around China. Over the weekend of December 20, 2025, NVDA became the
ServiceNow (NOW) Stock News on Dec. 20, 2025: Armis Deal Rumors, 5-for-1 Split, Analyst Targets and the 2026 Outlook

ServiceNow (NOW) Stock News on Dec. 20, 2025: Armis Deal Rumors, 5-for-1 Split, Analyst Targets and the 2026 Outlook

ServiceNow, Inc. (NYSE: NOW) heads into the weekend with investors still digesting one of the most turbulent stretches the enterprise software leader has seen this year: a fresh stock split, a confirmed AI acquisition closing, and intense market debate over
Alnylam Pharmaceuticals (ALNY) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025

Alnylam Pharmaceuticals (ALNY) Stock News, Forecasts and Analyst Outlook on Dec. 20, 2025

As of Saturday, December 20, 2025, investors are digesting a busy stretch of developments around Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)—from Nasdaq-100 index inclusion (effective Dec. 22) to fresh reimbursement tailwinds in the U.K. and continued focus on Amvuttra (vutrisiran) as
Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA (FIX) Stock News Today: Leadership Transition, S&P 500 Addition, Analyst Targets, and 2026 Outlook (Dec. 20, 2025)

Comfort Systems USA, Inc. (NYSE: FIX) heads into the final full week of 2025 with two headline catalysts in focus: a year-end leadership transition and a pending move into the S&P 500—both of which are shaping weekend headlines, analyst commentary,
Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics Stock (FOLD) Surges After $4.8B BioMarin Buyout: $14.50 Offer, Deal Timeline, Analyst Outlook (Dec. 20, 2025)

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is having the kind of week biotech traders both crave and fear: a sudden, definitive catalyst that snaps the stock to a new reality overnight. On Friday, December 19, shares jumped about 30% and hovered
Tata Motors Passenger Vehicles (TMPV) Stock: Latest News, Share Price Drivers, Forecasts and Analyst Outlook (Dec 20, 2025)

Tata Motors Passenger Vehicles (TMPV) Stock: Latest News, Share Price Drivers, Forecasts and Analyst Outlook (Dec 20, 2025)

Tata Motors Passenger Vehicles Ltd (NSE: TMPV | BSE: 500570) heads into the weekend with investors juggling two competing storylines: stronger India passenger vehicle (PV) and EV demand signals, and continued uncertainty around Jaguar Land Rover (JLR)—the profit engine that
Singapore Airlines Ltd Stock (SGX: C6L) in Focus: Latest News, Dividend Timeline, Analyst Targets and Outlook as of Dec. 20, 2025

Singapore Airlines Ltd Stock (SGX: C6L) in Focus: Latest News, Dividend Timeline, Analyst Targets and Outlook as of Dec. 20, 2025

Singapore Airlines Ltd (SIA) shares ended the latest trading session at S$6.32 (Dec. 19 close), leaving investors to weigh a familiar airline-stock tug-of-war: solid travel demand and healthy load factors versus softening yields, rising non-fuel costs, and ongoing uncertainty around
Evolution Mining Limited (ASX:EVN) Stock: Latest News, EVN Share Price Forecasts, and Analyst Outlook (20 December 2025)

Evolution Mining Limited (ASX:EVN) Stock: Latest News, EVN Share Price Forecasts, and Analyst Outlook (20 December 2025)

Evolution Mining Limited (ASX:EVN) heads into the final stretch of 2025 with its share price hovering near a fresh 52‑week high—after a year dominated by surging Australian‑dollar gold prices, record cash generation, and a growing debate over whether the stock
1 2 3 6
Go toTop